Pek Lum

Pek Lum is the Founder and CEO of Auransa, a clinical-stage, AI-driven biopharma focused on advancing therapies for various cancers. Prior to founding Auransa, they were a Scientific Director at Rosetta, contributing to the integration of data science into biological discovery after its acquisition by Merck. Pek has also held leadership roles at Ayasdi and served as an advisor for multiple startups in the biopharma space. In addition, they are an external advisory board member at the Schaefer School of Engineering and Science at Stevens Institute of Technology. As a first-generation Asian-American founder, Pek advocates for underrepresented voices in the entrepreneurial landscape.